Sharma R, Singh VJ, Chawla PA. Advancements in the use of platinum complexes as anticancer agents. Anticancer Agents Med Chem. 2022;22:821–35.

Article  CAS  PubMed  Google Scholar 

Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nature Rev Cancer. 2021;21:37–50.

Article  CAS  Google Scholar 

Johnstone TC, Suntharalingam K, Lippard SJ. The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery and Pt(IV) prodrugs. Chem Rev. 2016;116:3436–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wheate NJ, Walker S, Craig GE, Oun R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans. 2010;39:8113–27.

Article  CAS  PubMed  Google Scholar 

Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DilrubaAffiliated withDepartment of Clinical Pharmacy, Institute of Pharmacy, University of Bonn S, Kalayda GV. Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol. 2016;77:1103–24.

Article  Google Scholar 

Imran M, Ayub W, Butler IS. Photoactivated platinum-based anticancer drugs. Coord Chem Rev. 2018;376:405–29.

Article  CAS  Google Scholar 

Bai L, Gao C, Liu Q, Yu C, Zhang Z, Cai L, et al. Research progress in modern structure of platinum complexes. Eur J Med Chem. 2017;140:349–82.

Article  CAS  PubMed  Google Scholar 

Ahmad S. Kinetic aspects of platinum anticancer agents. Polyhedron. 2017;138:109–24.

Article  CAS  Google Scholar 

Brabec V, Hrabina O, Kasparkova J. Cytotoxic platinum coordination compounds. DNA binding agents. Coord Chem Rev. 2017;351:2–31.

Article  CAS  Google Scholar 

Jamieson ER, Lippard SJ. Structure, recognition and processing of cisplatin-DNA adducts. Chem Rev. 1999;99:2467–98.

Article  CAS  PubMed  Google Scholar 

Ahmad S, Isab AA, Ali S. Structural and mechanistic aspects of platinum anticancer agents. Transition Met Chem. 2006;31:1003–16.

Article  CAS  Google Scholar 

Ahmad S. Platinum–DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chem Biodiv. 2010;7:543–66.

Article  CAS  Google Scholar 

Rahiminezhad A, Moghadam ME, Divsalar A, Mesbah AW. How can the cisplatin analogs with different amine act on DNA during cancer treatment theoretically? J Mol Model. 2022;28:2.

Article  CAS  Google Scholar 

Wong D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Disc. 2005;4:307–20.

Article  Google Scholar 

Jung Y, Lippard SJ. Direct cellular responses to platinum-induced DNA damage. Chem Rev. 2007;107:1387–407.

Article  CAS  PubMed  Google Scholar 

Davies MS, Berners-Price SJ, Hambley TW. Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA. Inorg Chem. 2000;39:5603.

Article  CAS  PubMed  Google Scholar 

Kozelka J, Legendre F, Reeder F, Chottard J-C. Kinetic aspects of interactions between DNA and platinum complexes. Coord Chem Rev. 1999;190–192:61.

Article  Google Scholar 

Wang X, Guo Z. The role of sulfur in platinum anticancer chemotherapy. Anticancer Agents Med Chem. 2007;7:19.

Article  Google Scholar 

Reedijk J. Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell? Chem Rev. 1999;99:2499.

Article  CAS  PubMed  Google Scholar 

Berners-Price SJ, Kuchel PW. Reaction of cis-and trans-[PtCl2(NH3)2] with reduced glutathione studied by 1H, 13C, 195Pt and 15N- DEPT NMR. J Inorg Biochem. 1990;38:327.

Article  CAS  PubMed  Google Scholar 

Pinato O, Musetti C, Sissi C. Pt-based drugs: the spotlight will be on proteins. Metallomics. 2014;6:380–95.

Article  CAS  PubMed  Google Scholar 

Ahmad S, Isab AA, Al-Arfaj AR. Antitumor potential of platinum(II) complexes of selenium donor ligands. Metallomics. 2023;15:mfad020.

Article  PubMed  Google Scholar 

Chen S-H, Chang J-Y. New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment. Int J Mol Sci. 2019;20:4136.

Article  PubMed  PubMed Central  Google Scholar 

Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869–83.

Article  CAS  PubMed  Google Scholar 

Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33:9–23.

Article  CAS  PubMed  Google Scholar 

Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, et al. The drug-resistance mechanisms of five platinum-based antitumor agents. Front. Pharmacol. 2020;11:343.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacol Res. 2016;106:27–36.

Article  CAS  PubMed  Google Scholar 

Oun R, Moussa YE, Wheate NJ. The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans. 2018;47:6645–53.

Article  CAS  PubMed  Google Scholar 

Piccolini VM, Bottone MG, Bottiroli G, De Pascali SA, Fanizzi FP, Bernocchi G. Platinum drugs and neurotoxicity: effects on intracellular calcium homeostasis. Cell Biol Toxicol. 2013;29:339–53.

Article  CAS  PubMed  Google Scholar 

Xin Y, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115–24.

Article  Google Scholar 

Lemma K, Elmroth SKC, Elding LI. Substitution reactions of [Pt(dien)Cl]+, [Pt(dien)(GSMe)]2+, cis-[PtCl2(NH3)2] and cis-[Pt(NH3)2(GSMe)2]2+ (GSMe = S-methylglutathione) with some sulfur-bonding chemoprotective agents. J Chem Soc Dalton Trans. 2002;31:1281–6.

Zhang J-G, Lindup WE. Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem Pharmacol. 1994;47:1127–35.

Article  CAS  PubMed  Google Scholar 

Faraglia G, Fregona D, Sitran S, Giovagnini L, Marzano C, Baccichetti F, et al. Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay. J Inorg Biochem. 2001;83:31–40.

Article  CAS  PubMed  Google Scholar 

Hosseinzadeh S, Moghadam ME, Sheshmani S, Shahvelayati AS. Some new anticancer platinum complexes of dithiocarbamate derivatives against human colorectal and pancreatic cell lines. J Biomol Struc Dynam. 2020;38:2215–28.

Article  CAS